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A peptide from ostrich (Struthio camelus) egg white protein hydrolysate (OEWPH) was pu-
rified, characterized, and its antioxidant and enzyme inhibitory properties were evaluated.
The OEWPH was prepared using pepsin and pancreatin, and then fractionated using
reversed-phase high performance liquid chromatography. The antioxidant activity of the
WG-9 peptide was investigated based on its scavenging capacity for 1,1-diphenyl-2-
picrylhydrazyl (DPPH) radical, 2,20-azinobis (3-ethylbenzothiazoline-6-sulphonic acid)
diammonium salt (ABTS), superoxide (O2
), hydroxyl (OH), and lipid peroxidation inhi-
bition. The angiotensin-converting enzyme (ACE) inhibitory activity and kinetic parame-
ters of the peptide were determined using N-[3-(2-Furyl)acryloyl]-L-phenylalanyl-glycyl-
glycine (FAPGG) as a substrate. Tandem mass spectrometry analysis of the purified peptide
revealed a sequence of WESLSRLLG (MW: 1060 Da; WG-9). This peptide inhibited linoleic
acid oxidation and acted as a DPPH (IC50 ¼ 15 ± 0.4 mg/mL), ABTS (IC50 ¼ 130 ± 4.5 mg/mL),
superoxide (IC50 ¼ 160 ± 6.4 mg/mL), and hydroxyl (IC50 ¼ 150 ± 6.7 mg/mL) radical scavenger.
The ACE-inhibitory activity and kinetic parameters of the WG-9 peptide were determined,
showing an ACE inhibitory activity with IC50 of 46.7 ± 1.4 mg/mL. The parameters of peptide/
ACE interactions were investigated by molecule docking. Furthermore, viability assays
showed that the identified peptide had no cytotoxicity against an HFLF-PI-5 cell line. In
conclusion, the WG-9 peptide showed potent antioxidant and ACE-inhibitory activity.
Copyright © 2016, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan
LLC. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/3.0/).istry, Faculty of Science,
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Bioactive peptides are derived from different protein hydro-
lysates displaying various biological features, including
opiate-like, antihypertensive, antioxidative, mineral binding,
antimicrobial, antithrombotic, hypocholesterolemic, and
immunomodulatory properties [1e3]. Antioxidant peptides
can defend the human body against damages created by
reactive oxygen species (ROS), such as superoxide anion rad-
icals (O2
$), hydrogen peroxide (H2O2), singlet oxygen (1O2),
hypochlorous acid (HOCl$), and hydroxyl radicals (OH$). ROS
has the potential to attack macromolecules, such as lipid
membranes, enzymes, proteins, and DNA, thus leading to
many health disorders. Bioactive antioxidant peptides prin-
cipally consist of two to 20 amino acid residues, and their
bioactivity depends upon the amino acid sequence, hydro-
phobicity, and molecular weight of the peptides [4]. Many
studies focused on egg white proteins, especially from
chickens, because chicken eggs constitute one of the major
protein sources in our diet [5]. Egg white accounts for ~58% of
the entire egg mass and has a protein content of 10e12%,
comprising mainly of ovalbumin, ovotransferrin, ovomucoid,
globulins, and lysozyme [6].
High blood pressure could lead to the occurrence of coro-
nary heart disease, and its treatment decreases the risk of
cardiovascular disease and related irritations [7]. Regulation of
blood pressure is associated with the rennin-angiotensin
system (RAS), which plays a key role in the control of arterial
pressure [8]. Angiotensin I-converting enzyme (dipeptidyl
carboxy peptidase I, kinase II, E.C 3.4.15.1; ACE), belongs to the
class of zinc metalloproteases that requires zinc and chloride
for its function. ACE is a key renineangiotensin system (RAS)
enzyme that regulates arterial blood pressure through the
equilibrium of water and salt in the body. There are many
synthetic drugs that are ACE inhibitors, including captopril,
enalapril, lisinopril, etc. Because of some negative side effects
associated with these synthetic drugs, such as dry cough,
hyperkalemia, hypotension, renal failure, decrease in white
blood cells, and angioedema, attention has become focused on
naturally-derived drugs [9]. Antihypertensive peptides derived
from food proteins are safer than synthetic ACE inhibitors [10],
and milk, soybean, and egg proteins are sources of peptides
with potentially ACE-inhibitory effects [11]. These peptides are
obtained fromhydrolysis usingdifferent proteases. SomeACE-
inhibitorypeptideshavebeenderived fromovalbumin [12] and
ovotransferrin [13]. Egg white proteins are well-recognized for
their excellent functional and nutritional properties.
The aim of this study was to hydrolyze ostrich (Struthio
camelus) egg white protein with pepsin and panceratin and
identify the major peptides produced during enzymatic hy-
drolysis reaction. Furthermore, antioxidant, molecular dock-
ing, and ACE-inhibitory activity of the peptide were
investigated.2. Methods
Ostrich lungs were prepared from Mashhad Meat Industrial
Complex (Mashhad, Iran), and ACE from ostrich lung waspurified as previously reported [14]. Fresh ostrich egg was pre-
pared from Esteghlal market (Mashhad, Iran). Pepsin (porcine
gastricmucosa, EC 3.4.23.1), pancreatin (porcine pancreas), 1,1-
diphenyl-2-picrylhydrazyl (DPPH), glutathione (GSH), 2,20-
azino-bis(3-ethylbenzothiazoline-6-sulphonicacid) (ABTS), po-
tassium persulfate, potassium phosphate, trichloroacetic acid
(TCA), ferric chloride, 3-(4,5-dimethylthia-zol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT), ethylenediaminetetra-
acetic acid (EDTA), and trifluoroacetic acid (TFA) were pur-
chased from Sigma-Aldrich Chemical Co. (St. Louis, MO, USA).
Ultrafiltrationmembraneswith a 3-kDa cut off were purchased
fromMillipore (Bedford, MA, USA).
2.1. Enzymatic hydrolysis
The hydrolytic reaction was carried out according to the
method of Megı´as et al [15]. One hundred milliliters of ostrich
egg white was mixed with 400 mL distilled water and then
homogenized for ~10 minutes. The egg white was separately
hydrolyzed using various enzymes (pH 2.5 for pepsin in 0.1M
Glycine-HCl; pH 7.5 for solution of pancreatin in 0.1M phos-
phate buffer) at 37C. A ratio of 20:1 (w/w) egg white protein to
protease was used to prepare the hydrolysate. Pepsin (5 mg)
was used as the first protease at the beginning of the reaction
and after a 120-minute incubation, the pH was adjusted to
7.5mg and 5mg pancreatinwas added as the second protease.
The temperaturewasmaintainedat37Cthroughout theentire
process. In order to inactivate enzyme activity, each aliquot
was heated at 90C for 10minutes. Hydrolysates were clarified
by centrifugation at 10,000 g for 15 minutes and then passed
throughanultrafiltrationmembranewithacutoffof 3kDa.The
filtered solution was stored at 20C for further analyses.
2.2. Peptide purification
The resulting filtrate was fractionated using reversed-phase
high-performance liquid chromatography (RP-HPLC) on a
semi-preparative C8 column (10mm 250mm,manufactured
by Macherey-Nagel GmbH & Co., Duren, Germany). The mo-
bile phase included eluent A, which was composed of 0.1%
TFA in distilledwater (v/v), and eluent B, whichwas composed
of 0.098%TFA in acetonitrile. The elutionwas conducted using
a linear gradient of 5e50% eluent B at a flow rate of 2 mL/min
for 45 minutes. The absorbance of the eluted peaks was
monitored at 220 nm using a UV detector. All fractions were
collected and lyophilized for antioxidant activity assays. The
most active fraction was further purified on an analytical C18
RP-HPLC column (4.6 mm 250mm) using a linear gradient of
0.8% eluent B/min to obtain pure peptide.
2.3. Peptide identification and peptide synthesis
The peptide with the highest antioxidant activity was picked
out to identify its molecular mass and amino acid sequence.
The sample was desalted using Zip Tips (Millipore) and
analyzed by matrix-assisted laser desorption/ionization-time
of flight (MALDI TOF)-TOF mass spectrometer using a 5800
Proteomics Analyzer (Applied Biosystems at Proteomics In-
ternational Pty. Ltd., Nedlands,Western Australia). The amino
acid sequence was determined by the de novo sequencing
j o u rn a l o f f o o d a nd d r u g an a l y s i s 2 4 ( 2 0 1 6 ) 3 3 2e3 4 2334method. The PEAKS Studio version 4.5 SP2 (Bioinformatics
Solutions Inc., Waterloo, ON, Canada) was used for analysis of
the derived tandem mass spectrometry (MS/MS) spectra.
The identified peptide was synthesized using the solid-
phase method (GL Biochem Shanghai Ltd., Shanghai, China)
using the standard Fmoc (9-fluorenyl-methoxycarbonyl)
chemistry. Crude synthetic peptides were subjected to RP-
HPLC to purify the peptide using a semi-preparative C8 col-
umn (10 mm  250 mm, MachereyeNagel GmbH & Co.).2.4. DPPH radical scavenging assay
Five hundred microliters of peptide sample at concentrations
of 0.007e1 mg/mL was mixed with 500 mL of 99.5% ethanol
containing 0.02% DPPH. This mixture was kept in the dark at
room temperature for 30 minutes before measuring the
absorbance at 517 nm using a spectrophotometer (Shimadzu
UV mini 1240; Shimadzu Scientific Instr. Inc., Durham, NC,
USA). As a control, distilled water was used instead of the
sample.Glutathione (GSH)at concentrationsof 0.007e1mg/mL
was also used as a positive control for comparison, and DPPH
radical scavenging activity was calculated as follows [16]:
Radical scavenging activity (%) ¼ (AControl  ASample/AControl)
 100 (1)
2.5. ABTS radical scavenging activity assay
ABTS radical scavenging activity was determined as described
by Hasbal et al [17] with some modifications. The resulting so-
lution obtained from the reaction of ABTS (7mM inwater) with
potassium persulfate (2.45mM final concentration) was placed
in the dark for 16 hours to produce ABTSþ radical. The resulting
solution was diluted bymixing 1 mL ABTS solution with 50mL
ethanol to obtain an absorbance of 0.70 ± 0.02 at 734 nm.
Samples (10mL of a peptideorGSHat 1mg/mL)weremixedwith
990 mL ABTSþ radical cation solution and incubated for 6 mi-
nutes, and then the absorbance was measured at 734 nm. All
solutions were prepared daily, and all determinations were
carried out in triplicate. Appropriate solvent blanks [negative
controls (NC)]were run for each assay, while GSHwas used as a
positive control (PC). The percentage of ABTSþ radical inhibi-
tion was calculated using the equation below:
Inhibition (%) ¼ (AControl  ASample/AControl)  100 (2)
where AControl represents the absorbance without sample
and ASample represents the absorbance of the sample.2.6. Hydroxyl radical scavenging assay
Thehydroxyl radical scavengingassaywascarriedoutbasedon
a method described by Girgih et al [7]. Peptide, GSH, and 1,10-
phenanthroline (0.75mM) were each separately dissolved in
phosphate buffer (0.1M, pH 7.4), while FeSO4 (0.75mM) and
0.01%H2O2wereeachseparatelydissolved indistilledwater.An
aliquot (50 mL) of peptide or GSH (equivalent to a final assayconcentration of 1mg/mL) or buffer (control) was first added to
a 96-well plate, followed by the addition of 50 mL 1,10-
phenanthroline and 50 mL FeSO4. To initiate reactions in the
wells, 50 mLH2O2 solutionwas added to themixture,whichwas
then covered and incubated at 37C for 60 minutes with
shaking. Thereafter, the absorbance of the mixtures was
measured at 536 nm every 10 minutes for a period of 60 mi-
nutes. The reactionmixture without any antioxidant was used
as thenegative control, and themixturewithoutH2O2was used
as the blank. The hydroxyl radical scavenging activity (HRSA)
was calculated as follows based on absorbance change (DA):
HRSA (%) ¼ [(DAControl/min  DASample/min/DAControl/min)
 100] (3)
2.7. Superoxide scavenging activity assay
The superoxide radical scavenging activity was determined
according to a method described by Pownall et al [18]. An
aliquot (80 mL) of the peptide sample or reduced GSH was
mixed (1 mg/mL final concentration) with 80 mL Tris-HCl
buffer (50mM, pH 8.3) containing 1mM EDTA directly into a
clear bottom 96-well plate. Forty microliters of 1.5mM pyro-
gallol dissolved in 10mM HCl was added to each well. A
mixture containing 160 mL Tris-HCl buffer and 15 mL pyrogallol
solution was used as control. Absorbance was measured at
420 nm for 4 minutes at room temperature. The antioxidant
activity was determined as the percentage of inhibiting py-
rogallol auto-oxidation, which was calculated from the
absorbance in the presence or absence of pyrogallol and the
sample [18].
Superoxide scavenging activity (%) ¼ [(DA420Control/min
 DA420Sample/min)/DA420control/min]  100 (4)
2.8. Inhibition of linoleic acid auto-oxidation
Lipid peroxidation-inhibition capacity of the peptide was
determined in a linoleic acidmodel system [19]. Briefly, 1.3mg
of peptide or GSH was dissolved in 10 mL 50mM phosphate
buffer (pH 7.0) and added into a solution containing linoleic
acid (0.13mL) and 99.5% ethanol (10mL). The final volumewas
adjusted to 25 mL with distilled water, and the resulting
mixture was incubated in a storage bottle with a screw cap at
60 ± 1C in a dark room. The degree of linoleic acid oxidation
was evaluated at 24-hour intervals by measuring the ferric
thiocyanate concentration. In practice, the resulting mixture
(0.1mL) was mixed with 4.7mL of 75% ethanol, 0.1mL of 30%
ammonium thiocyanate, and 0.1mL of 20mM ferrous chloride
dissolved in 3.5% HCl. After 3 minutes, the amount of thio-
cyanate was measured by reading the absorbance at 500 nm,
following color development with FeCl2 and thiocyanate.
2.9. ACE-inhibitory activity and IC50 determination
The concentration of ACE inhibitor required to inhibit 50% of
ACE activity was defined as the IC50 value. The ACE-inhibitory
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by Holmquist et al [20] with slight modifications. The reaction
mixture was composed of 22 mL ACE (50 mU/mL), 50 mL WG-9
peptide (0.019, 0.039, 0.078, or 0.156 mg/mL final concentra-
tion), and 100 mL N-[3-(2-Furyl)acryloyl]-L-phenylalanyl-
glycyl-glycine (FAPGG) (0.5mM) as a substrate and 150 mL ACE
buffer [50mM Tris-HCl (pH 7.5), 0.3M NaCl, and 1mM ZnCl2].
The control sample contained 22 mL ACE (50 mU/mL), 100 mL
FAPGG, and 200 mL ACE buffer. The reaction was performed at
340 nm for 2 minutes. ACE-inhibitory activity was calculated
as follows [21]:
ACE inhibition (%) ¼ [1  (DAinhibitor/DAControl)]  100 (5)
The IC50 was determined using the plot of inhibition per-
centage against five peptide concentrations. The IC50 value
was calculated from semi-logarithmic plots.
2.10. Kinetic measurements
Various concentrations of N-[3-(2-Furyl)acryloyl]-L-phenyl-
alanyl-glycyl-glycine (FAPGG) substrate (0.011mM, 0.023mM,
0.046mM, 0.093mM, and 0.187mM) were incubated under ACE
assay conditions as described above in the absence or pres-
ence of 0.46 mg/mL and 0.09 mg/mL inhibitory peptide WG-9
at 37C. The inhibitory kinetics were examined by
Lineweaver-Burk plots, using the vertical axis for velocity and
the horizontal axis for FAPGG concentration. The Michaelis
constant (KM) and maximum velocity (Vmax), along with the
inhibition type of the peptide, were determined graphically
using LineweavereBurk plots. The inhibitor constant (Ki) was
estimated from a Dixon plot [22].
2.11. Molecular docking analysis
Automated molecular docking studies of the WG-9 peptide on
the ACE-binding site were performed using Molegro Virtual
Docker (MVD 2010, version 4.2.0, for Windows 32; CLC Bio,
Aarhus, Denmark). The three-dimensional structures of tACE
(for the C-domain, PDB ID: 1UZF), which belongs to the com-
plex of ACE-captopril and human somatic ACE (for the N-
domain, PDB ID: 2C6N) were used. The docking runs were
performedwith a radius of 20A,with coordinates x:64.977, y:
18.645, and z: 21.183. The Molecular Operating Environ-
ments (MOE; 2009.10 Chemical Computing Groups, Montreal,
Quebec, Canada) andMolegroMolecularViewer (MMV2012.2.5
for Windows) were used to calculate interaction parameters
between WG-9 peptide and ACE. Total binding energy, inter-
molecular energy, electrostatic energy, and the binding affin-
ity (pKi) of enzyme-peptide complex were calculated.
2.12. Cytotoxicity assay
Cytotoxicity assays were conducted according to the method
of Mossmann [23]. The HFLF-PI 5 cell line (C-169) derived from
human lung tissue was purchased from The National Cell
Bank of Iran (Pasteur Institute of Iran, Tehran, Iran) and was
cultured andmaintained in Rosewell ParmMemorial Institute
medium supplemented with 100 U/mL penicillin, 0.1 mg/mLstreptomycin, and 10% fetal bovine serum and maintained at
37C under a humidified atmosphere and 5% CO2. Cells were
seeded in complete medium in a 96-well plate at a density of
1  105 cells/mL, and 0.1 mL of cell suspension was seeded per
well into 96-well microtiter plates. After reaching 75%
confluence, the cells were incubated with different concen-
trations of the sample (01mg/mL) for 24 hours, 48 hours, and
72 hours. Phosphate-buffered saline (PBS) was used as a con-
trol. The medium was then discarded and the adherent cells
were washed twice with PBS, then 20 mL of MTT stock solution
(5 mg/mL in PBS) was added to each well, and the plates were
further incubated overnight at 37C. Then, 100 mL dimethyl
sulphoxide was added to each well in order to solubilize the
formazan crystals produced by the viable cells. After complete
dissolving of formazan blue, the absorbance was measured at
570 nm as a reference wavelength using an enzyme-linked
immunosorbent assay (ELISA) plate reader (ELX800 ELISA
reader; Bio-Tek Instruments, Winooski, VT, USA). The per-
centage of cytotoxicity was calculated as follows [23]:
Cytotoxicity (%) ¼ (1  AbsSample)/AbsControl)  100 (6)
2.13. Hemolytic activity
Hemolytic activity of the WG-9 peptide was studied using
fresh human red blood cells (RBCs) obtained from the pe-
ripheral blood (Oþ). Five milliliters of blood in 50 mL EDTA was
centrifuged at 4500 g for 10 minutes, then plasma (superna-
tant) was discarded and the pelleted RBCs were washed three
times with PBS consisting of 10mM phosphate buffer and
130mM NaCl (pH 7.4) and centrifuged at 4500 g until total
isolation of erythrocytes from plasma was completed. The
purified RBCs were diluted with 20 mL PBS buffer. To assess
hemolytic activity, 10 mL WG-9 peptide at final concentrations
of 12.5 mg/mL, 25 mg/mL, 50 mg/mL, 100 mg/mL, and 200 mg/mL
was added to 190 mL of cellular suspension. Themixtures were
incubated for 30 minutes at 37C. Following centrifugation of
samples at 4000 g for 5 minutes, 100 mL supernatant was
diluted with 1 mL PBS and the free hemoglobin in the super-
natant was measured by a UV-Vis spectrophotometer at
560 nm. PBS was used as a negative control.3. Results
3.1. Isolation of antioxidative peptide
In this study, the antioxidant activity of a peptide resulting
from enzymatic hydrolysis of ostrich egg white with pepsin
and pancreatin was evaluated. This protein hydrolysis was
subjected to HPLC fractionation (Figure 1A). Only one main
peak was observed on the chromatogram under the condi-
tions applied for hydrolyzing. The use of a pepsin-pancreatin
model for gastero-intestinal digestionmay be themain reason
we observed a low number of peaks in the HPLC chromato-
gram. After collecting the fraction, it was freeze-dried and
identified by MS/MS. As shown in Figure 1B, the deduced
sequence from the fragment ions (b and y fragments) was
Figure 1 e (A) Semi-preparation of OEWPH on a C8 column (10 mm £ 250 mm). Nearly 15 mg OEWPH was dissolved in
solvent A (water containing 0.1% TFA) and was injected on the column. Bymonitoring the absorbance at 214 nm, the elution
was accomplished at a flow rate of 2 mL/min using a linear gradient of acetonitrile as solvent B (5e45% for 40 minutes). The
major peak, which appeared after 26 minutes, was chosen to be identified by MALDI-TOF/TOF sequencing. The y-axis
indicates absorbance units (mAU). Characterization of the antioxidant peptide: (B) MS/MS spectrum of the purified peptide
(upper section) and analysis of MS/MS spectrum for purified peptide (lower section, the unit of X-axis is m/z). By manual
calculation, the sequence of this peptide is displayed with the fragmentations observed in the spectrum. MALDI-TOF/
TOF ¼ matrix-assisted laser desorption/ionization-time of flight; MS/MS ¼ tandem mass spectrometry; OEWPH ¼ ostrich
egg with protein hydrolysate.
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the molecular weight of 1060.22 Da. We previously purified
and identified a bioactive peptide named DG-10 from ostrich
egg hydrolysate showing wound-healing properties [24]. Here,
the antioxidant and ACE inhibitory activity of the WG-9 pep-
tide was reported. For this purpose, the WG-9 peptide was
then synthesized using a solid-phase method with a yield of
75%. The synthetic peptide was purified up to 98% by C8 RP-HPLC using acetonitrile containing 0.1% TFA as the mobile
phase. The collected fraction was lyophilized and used for
further characterization.
3.2. Antioxidant activity
Antioxidant properties of the identified peptide from ostrich
egg white proteins were evaluated. It was found that systems
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the radical-scavenging activities of a desired antioxidant [25].
Therefore, in this study, the DPPH, ABTS, hydroxyl, and su-
peroxide radical-scavenging activities of the peptide were
investigated. Figure 2A shows the DPPH-radical scavenging
activity of the WG-9 peptide as compared to GSH. At 15 mg/mL
GSH and WG-9, 67% and 50% DPPH-radical scavenging was
observed, respectively. The ABTS-radical, superoxide-radical,
and hydroxyl-radical scavenging capacities of the peptide
were also measured. Similar to the DPPH-scavenging activity,
the ability of the peptide toward scavenging ABTS radical,
superoxide radical, and hydroxyl radical also increased rela-
tive to concentration (Figure 2BeD). The IC50 values of theFigure 2 e (A) DPPH-, (B) hydroxyl-, (C) superoxide-, (D) ABTS-ra
inhibition of the WG-9 peptide. GSH was used as a positive contr
the lipid peroxidation assay. The assay was carried out in tripl
sulphonic acid) diammonium salt; BHA ¼ butylated hydroxyan
GSH ¼ glutathione.peptide scavenging activity were 15 ± 0.4 mg/mL and
130 ± 4.5 mg/mL for DPPH and ABTS radicals, respectively. Our
results also showed that the WG-9 peptide had IC50 values of
160 ± 6.4 mg/mL and 150 ± 6.7 mg/mL for hydroxyl- and
superoxide-radical scavenging, respectively. GSH revealed
more potent antioxidant properties that WG-9 in all assays,
with an IC50 < 15 mg/mL.
3.3. Lipid peroxidation inhibition
The WG-9 peptide was able to protect linoleic acid from per-
oxidation damage during a 7-day period. Owing to the hy-
drophobicity of antioxidants, which is important fordical scavenging activities and (E) lipid peroxidation
ol for scavenging properties, while BHA was considered for
icate. ABTS ¼ 2,20-azinobis (3-ethylbenzothiazoline-6-
isole; DPPH ¼ 1,1-diphenyl-2-picrylhydrazyl;
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Figure 3 e (A) ACE inhibition curve at various
concentrations of WG-9 peptide. (B) Lineweaver-Burk plots
for ACE in the presence or absence of the peptide. The
equations for the plot are as follows: y ¼ 0.0003x þ 0.0034
(R2 ¼ 0.996) for control (without peptide);
y ¼ 0.0004x þ 0.0035 (R2 ¼ 0.999) at 46 mg/mL WG-9; and
y ¼ 0.00069x þ 0.0034(R2 ¼ 0.995) at 90 mg/mL WG-9. (C)
The secondary plot for the WG-9 peptide is the competitive
inhibitor. ACE ¼ angiotensin-converting enzyme.
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presence of hydrophobic amino acids within the purified
peptide may have contributed to lipid peroxidation-inhibitory
activity by increasing the solubility of peptides in lipids,
thereby facilitating better interaction with radical species. As
shown in Figure 2E, the peptide inhibited the formation of
primary oxidation products significantly throughout the
oxidation period as compared to the natural antioxidant
butylated hydroxyanisole (BHA). However, the inhibitory ac-
tivity of BHAwasmore efficient than that of theWG-9 peptide.
3.4. ACE-inhibitory activity of the WG-9 peptide
The ACE-inhibitory activity of the WG-9 peptide was deter-
mined in vitro. The IC50 (amount of peptide required to inhibit
50% of the ACE activity) is shown in Figure 3A. The ACE-
inhibitory activity of the WG-9 peptide at 156 mg/mL was
91.48%, with an IC50 value of 46.7 ± 1.4 mg/mL.
3.5. Inhibition mechanism and insight into kinetics
study
The ACE-inhibitory pattern of the WG-9 peptide was investi-
gated using a Lineweaver-Burk plot [26]. The ACE-inhibition
pattern of the purified peptide explained how it binds to ACE
and inhibits enzyme activity. The Lineweaver-Burk plot of
ACE-inhibitory activity is shown in Figure 3B. The ACE-
inhibition pattern demonstrated that the WG-9 peptide had
competitive properties, suggesting that this inhibitor peptide
was able to interact with the ACE active site and prevent
substrate binding. The maximum velocity of the enzyme re-
action (Vmax) was 294mM/min and the Michaelis-Menten
constant (KM) of the reaction without the WG-9 peptide (con-
trol) was 0.088mM, while, these parameters were 0.118mM at
0.046 mg/mL WG-9 and 0.203mM at 0.09 mg/mL WG-9,
respectively. The inhibitor constant (Ki) was determined
from the intercept on the axis of the secondary plot of KM
against peptide concentration (I), with a calculated Ki value for
the WG-9 peptide of 0.065 mg/mL (Figure 3C).
3.6. Molecular docking
The WG-9 peptide was docked separately with the N- and C-
domains of ACE. Figure 4 shows the docking mode of WG-9
with ACE. The best docking score was selected among
twenty docking runs. Results revealed thatWG-9 occupied the
binding pocket of the ACE active site. The peptide is located in
the binding site of the N-domain, interacting with some polar
residues, including Arg500, Arg381, Ser378, Tyr338, Tyr369,
Glu362, His331, Lys489, Gln259, Glu431, Glu262, Gln259,
Ala334, and Asn494 (Figure 4A). These residues can form
hydrogen bonds or electrostatic interactions with the peptide.
The N-domain docking score (214.0 Kcal/mol) was selected
among twenty docking runs. Figure 4B displays the interaction
map along with the docking mode of the WG-9 peptide with
the ACE C-domain. The highest docking score (245.0 Kcal/
mol) was obtained for C-domain docking under the afore-
mentioned conditions. The peptide was inserted into the
binding site of ACE. Some amino acids play a role via van der
Waals forces, while others play a role via electrostaticinteractions. In the ACE/WG-9 interaction, the fifteen residues
surrounding the ACE active site, Arg381, Ser378, Tyr24, Tyr338,
Ala334, Asn494, Arg500, Glu362, Lys489, Gln259, Ser260,
Glu262, Glu431, Ser260, and His331, contributed significantly
in stabilization of the peptide-ACE complex. Ala334, Arg500,
Arg381, and Glu362 were especially important components in
the ACE active site andwere partly responsible for the binding
strength. The estimated values of binding affinity (pKi), the
intermolecular energy, binding energy, and electrostatic en-
ergy for WG-9-ACE complex are shown in Table 1.
Figure 4 e (A) Docking results of WG-9 and the N-terminal region of tACE and (B) WG-9 and the C-terminal region of tACE. All
interactions in the active site have been simplified. Hydrophobic, polar, and acidic residues of ACE are represented by green,
violet, and red rings, respectively. Green arrows show hydrogen bands from donor atom to acceptor. ACE ¼ angiotensin-
converting enzyme.
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Table 1 e Estimated values of the binding affinity (pKi) and interaction energies for the peptide WG-9-ACE complex.
System pKi (mM) Binding
energy (KJ/mol)
Intermolecular
energy (KJ/mol)
Steric and hydrogen-bonding
energy (KJ/mol)
Electrostatic
energy (KJ/mol)
WG-9-N-domain 24.22 241.0 13.13 210.8 16.0
WG-9-C-domain 25.31 245.0 13.13 214.0 18.2
ACE ¼ angiotensin-converting enzyme.
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and hemolytic activity
The cytotoxic effects of the purified peptide on humanHFLF-PI
5 cells were evaluated (Figure 5A). The peptide had no signif-
icantly effect on cell viability (p < 0.05) over 24 hours, whereas,
cell viability was significantly reduced after 48-hours and 72-
hours treatment with the WG-9 peptide (p < 0.05). The he-
molytic activity of the WG-9 peptide was assessed on blood
erythrocytes (Figure 5B), with the results showing that the
WG-9 peptide had no hemolytic effect on RBCs.0
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Figure 5 e (A) Time- and dose-dependent effects of theWG-
9 peptide on viability of HFLF-PI-5 cells evaluated by MTT
assay. The peptide had no significant effect on the treated
cells after 24 hours (p < 0.05). (B) Hemolytic activity of the
WG-9 peptide against human erythrocytes. The assay was
carried out in triplicate. MTT ¼ 3-(4,5-dimethylthia-zol-2-
yl)-2,5-diphenyltetrazolium bromide.4. Discussion
Based on the radical-scavenging assessments, we speculated
that the peptide isolated from ostrich egg white protein was
capable of converting free radicals into more stable products
and completing the cascade of radical-chain reactions. Our
results showed that the WG-9 peptide possessed the highest
antioxidant activity in DPPH-radical scavenging assays
(IC50 ¼ 15 ± 0.4 mg/mL), while antioxidant activity of the WG-9
peptide against ABTS, superoxide, and hydroxyl radicals
ranges from 130 ± 4.5 mg/mL to 160 ± 6.4 mg/mL. Thus, the
predominant antioxidantmechanism of the identified peptide
involves DPPH-radical scavenging.
Ovotransferrin is one of the major proteins existing in egg
white proteins, and peptides identified from digested ovo-
transferrin have exhibited antioxidant properties [27]. Lyso-
zyme can also protect against acute and chronic oxidative
stress [26]. Tanzadehpanah et al [28] reported a peptide from
enzymatic hydrolysis of ostrich egg white using a-chymo-
trypsin, pepsin, trypsin, and papain. The peptide sequence
LTEQESGVPVMK (MW: 1317.65 Da) showed IC50 values asso-
ciated with DPPH- and hydroxyl-radical scavenging as
28.6 ± 1.08 mg/mL and 137 ± 4.79 mg/mL, respectively [28]. In
comparison to the above-mentioned peptide derived from
ostrich egg hydrolysate, the WG-9 peptide exhibited a greater
degree of scavenging ability against both DPPH and hydroxyl
radicals.
Lipid peroxidation is a major cause of quality change and
deterioration processes affecting food flavor, texture, and
appearance. Peroxidation also affects nutritive value of foods
and may cause numerous diseases [29]. In the identified
sequence, two nonpolar aliphatic amino acids, Leu and Gly,
participated in antioxidant properties of the peptide and were
correlated with those reported in previous studies.
Through the use of polyunsaturated fatty acids, inhibition
of peroxidationwas examined in the presence of the identified
peptide. The three amino acid residues within the peptide
sequence, Trp, Gly, and Leu, were assumed to have contrib-
uted to the radical scavenging activity of the peptide. Aro-
matic amino acids can donate protons to electron-deficient
radicals and are effective in radical-scavenging activity [30].
The hydrophobic properties of the peptides play an important
role in quenching lipid-derived radicals [31]. Sampath Kumar
et al [32] isolated a peptide with high antioxidant properties
from horse mackerel viscera protein. The isolated peptide
with four amino acids (ACFL) showed greater levels of inhi-
bition of the oxidation process relative to a-tocopherol.
Similar to the ACFL peptide, the isolated peptide in this study
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presence of hydrophobic amino acid residue Leu plays an
important role in the inhibition of lipid peroxidation. In a
previous study, a peptide (HGPLGPL) presenting hydrophobic
amino acids, such as Gly, Leu, and Pro, from fish skin hydro-
lysate exhibited a strong activity against ROS and linoleic acid
peroxidation [33].
Examination of the peptide in HFLF-PI-5 cells showed that
the WG-9 peptide had no significant cytotoxic effect after 24-
hours treatment. The percentage of cell viability after 48-
hours and 72-hours treatment decreased to 80% as
compared to the control. Furthermore, exposure of human
RBCs to the WG-9 peptide resulted in no significant hemo-
globin release (p < 0.05), demonstrating that the peptide does
not disturb RBC membranes, resulting in release of hemo-
globin. One reason for this findingmay be that the peptidewas
derived from a natural food source.
As reported, ACE prefers substrates or competitive in-
hibitors that mainly have hydrophobic amino acid residues at
the N/C-termini [34]. Therefore, the presence of Leu, Trp, and
Gly in the peptide appears to play an important role in ACE-
inhibitory activity. Some antihypertensive peptides derived
from egg white proteins have been identified, including IVF,
YAEERYPIL, RADHPFL FFGVRCVSP, ERKIKVYL, and FRAHPFL
obtained from the peptic digestion of ovalbumin [11,35], and
KVREET derived from the chymotryptic digestion of ovo-
transferrin [36]. ACE-inhibitory peptides isolated from eggs
are mainly products of single enzymatic hydrolysis and they
are relatively large, while the results of this study were ob-
tained from two-step hydrolysis of ostrich egg white protein
with gastrointestinal enzymes. In one study, after two-stage
hydrolysis of cooked eggs, three potent ACE-inhibitory pep-
tides, MKR, RGT, and VAW, were isolated [37]. Majumder and
Wu [38] also reported that digestion of cooked eggs in vitro
generated a number of potent, low-molecular weight ACE-
inhibitory peptides. It was reported that short-chain pep-
tides, especially di- and tri-peptides, were more easily absor-
bed in the intestinal tract as compared to larger ones [39]. Trp,
Tyr, Phe, and Pro are the most favorable C-terminal amino
acids in peptides, because these amino acids made the most
important contributions to substrate binding in the ACE active
site. Our findings indicated that the presence of Trp in the N-
terminal region of the peptide promoted ACE inhibition.
Furthermore, the presence of Leu and Gly in our peptide also
may have played important roles in ACE-inhibitory activity.
Some of ACE inhibitors derived from food-protein hydro-
lysates are competitive inhibitors [34]. These were able to
enter and interact with the ACE active center and prevent
substrate binding. The structure of peptides is a prominent
factor affecting ACE-inhibitory properties. Although most of
the reported peptides have a competitive ACE-inhibition
pattern, some of the isolated peptides showed non-
competitive ACE-inhibition patterns. Results indicated that
aromatic amino acids at the C-terminal region and branched-
chain aliphatic amino acids at the N-terminal region were
suitable for peptide binding to ACE as a competitive inhibitor.
However, other reports demonstrated that inhibitory peptides
possess an aliphatic amino acid residue at their C-terminal
region [37,40]. These findingswere consistent with our results,
showing that the WG-9 peptide had a Trp at its N-terminus.Our experimental results showed thatWG-9 was a potent ACE
inhibitor. To confirm this, molecular modeling of the peptide-
ACE complex was performed using molecular docking soft-
ware. Docking experiments performed with stable confor-
mations of the WG-9 peptide offered a molecular basis for the
inhibitory activity of the peptide on tACE. This enzyme con-
sists of a single polypeptide chain of 625 residues arranged in
two subdomains, 1 (residues 1e292) and 2 (residues 293e623),
around a central groove, where the active site of the enzyme is
located. The enzyme consists predominantly of extended a-
helices associated with a few short b-sheets. Two ACE do-
mains have distinct functions, including the N-terminal
domain that participates in processing bioactive peptides
(such as the hematopoietic peptide, N-acetyl-seryl-aspartyl-
lysyl-proline) and less in RAS, while the C-terminal domain
(tACE) plays a significant role in RAS and regulation of hy-
pertension. The docking results demonstrated that the WG-9
peptide had greater binding affinity to the C-terminal
domain of ACE (pKi ¼ 25.31), with a binding energy of
245.0 Kcal/mol. This could be an advantage for the WG-9
peptide acting as a more potent anti-hypertension compo-
nent. The binding energy is critical in the identification of the
most effective binder to a given target between a set of
different ligands [41]. Our results revealed that residues, such
as Arg (cationic), Glu (anionic), Leu, Gly, and Trp (nonpolar)
interact with the binding site of ACE. Additionally, the pres-
ence of nonpolar amino acids, such as Trp, Leu, and Arg, in
unique positions in the sequence can strengthen anti-ACE
activity.
In conclusion, these results suggested that the purified
peptide may be a promising antioxidant for functional food
ingredients and/or pharmaceuticals. However, further studies
are required to investigate in vivo antioxidant or antihyper-
tensive activities.Conflicts of interest
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